PLAT and stroke disorder: Remarkably, the successful development of new therapeutic approaches to treat acute ischemic stroke patients, including thrombolysis with tissue plasminogen activator (tPA) [2] and mechanical removal of the occluding clot [3], has led not only to a 33.7% and 18.2 % drop in the relative rate of stroke death and the actual number of stroke deaths, respectively [1], but also to an increase in the number of patients that survive an acute ischemic stroke with different degrees of neurological disability.